Clinical trials recruiting in Tver', Russia

Phase breakdown

Conditions recruiting in Tver', Russia

Recruiting trials in Tver', Russia

• A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
  NCT05654454 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
  NCT07052578 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
  NCT07164183 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: Female
• Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
  NCT06930859 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Tver', Russia?

4 recruiting trials have at least one study site in Tver', Russia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.